New approach for sampling gut bacteria to illuminate bacteria's role in disease
5/21/2014
Scientists at Forsyth, Massachusetts General Hospital and the Harvard School of Public Health have developed a new protocol for collecting saliva and stool samples for genomic and transcriptomic...
Boehringer Ingelheim has announced new overall survival data of two Phase III clinical trials (LUX-Lung 3 and LUX-Lung 6).
Wide variation in lung cancer rates globally
5/20/2014
The only recent comprehensive analysis of lung cancer rates for women around the world finds lung cancer rates are dropping in young women in many regions of the globe, pointing to the success of...
Ultra-sensitive nano-chip capable of detecting cancer at early stages
5/20/2014
Today, the majority of cancers are detected on the macroscopic level, when the tumor is already composed of millions of cancer cells and the disease is starting to advance into a more mature phase.
Destroying brain tumors using herpes-loaded stem cells
5/20/2014
Harvard Stem Cell Institute (HSCI) scientists at Massachusetts General Hospital have a potential solution for how to more effectively kill tumor cells using cancer-killing viruses.
Distress during breast cancer treatment reduced by cognitive behavioral or relaxation training
5/20/2014
Can psychological intervention help women adapt to the stresses of breast cancer?
Important findings presented by Mount Sinai at the 2014 American Urological Association Meeting
5/20/2014
Immune response to prostate-specific antigen, live birth rate adversely affected by increasing paternal age, comparison of treatment modalities for benign prostatic hyperplasia, understanding...
Suppressing prostate cancer progression with MicroRNA
5/20/2014
About one in seven men will develop prostate cancer over the course of a lifetime, and about one in 36 men will die from it.
Less frequent echocardiographic screening of childhood cancer survivors is effective for detecting asymptomatic left ventricular dysfunction (ALVD) and is more cost-effective than following the...
Dogs 'sniff out prostate cancer with 98% accuracy,' study finds
5/19/2014
New research finds that two highly trained dogs were able to detect prostate cancer in human urine samples with up to 98% accuracy, opening the doors for a new screening method.
